Arizona State Retirement System boosted its position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 2.4% in the 4th quarter, according to its most recent filing with the Securities ...
REGENXBIO Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Updates
Biologics Licensing Application (BLA) for clemidsogene lanparvovec (RGX-121) submitted and on track for potential FDA approval 2H 2025; strategic partnership with Nippon Shinyaku aims to expand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback